Enovix (NASDAQ:ENVX) Updates Q4 Earnings Guidance

Enovix (NASDAQ:ENVXGet Free Report) updated its fourth quarter earnings guidance on Tuesday. The company provided earnings per share guidance of ($0.21)-($0.15) for the period, compared to the consensus earnings per share estimate of ($0.20). The company issued revenue guidance of $8-$10 million, compared to the consensus revenue estimate of $7.37 million. Enovix also updated its Q4 2024 guidance to -0.210–0.150 EPS.

Enovix Stock Performance

NASDAQ ENVX traded down $1.47 during trading hours on Thursday, reaching $9.01. The company’s stock had a trading volume of 29,605,543 shares, compared to its average volume of 5,623,950. The business has a 50-day simple moving average of $10.06 and a 200 day simple moving average of $11.05. The stock has a market cap of $1.59 billion, a PE ratio of -5.59 and a beta of 1.98. The company has a current ratio of 3.98, a quick ratio of 3.84 and a debt-to-equity ratio of 0.97. Enovix has a 52 week low of $5.70 and a 52 week high of $18.68.

Enovix (NASDAQ:ENVXGet Free Report) last released its quarterly earnings results on Tuesday, October 29th. The company reported ($0.17) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.03. Enovix had a negative return on equity of 91.21% and a negative net margin of 1,434.34%. The company had revenue of $4.30 million for the quarter, compared to analysts’ expectations of $4.11 million. During the same quarter in the previous year, the company posted ($0.27) earnings per share. Equities research analysts predict that Enovix will post -1.2 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on ENVX. JPMorgan Chase & Co. decreased their price objective on Enovix from $18.00 to $15.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Cantor Fitzgerald restated an “overweight” rating and set a $30.00 price objective on shares of Enovix in a research report on Wednesday. Benchmark restated a “buy” rating and set a $25.00 price objective on shares of Enovix in a research report on Wednesday. Canaccord Genuity Group raised their price objective on Enovix from $17.00 to $20.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. Finally, Janney Montgomery Scott lowered Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price objective for the company. in a research report on Thursday. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Enovix currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.50.

Read Our Latest Stock Report on ENVX

Insider Transactions at Enovix

In other news, insider Arthi Chakravarthy sold 35,000 shares of Enovix stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $13.00, for a total transaction of $455,000.00. Following the sale, the insider now owns 343,305 shares of the company’s stock, valued at approximately $4,462,965. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 15.70% of the stock is owned by insiders.

About Enovix

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Stories

Earnings History and Estimates for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.